program
ribosom
frameshift
use
mani
virus
regul
product
structur
enzymat
protein
alter
frameshift
effici
disrupt
viru
life
cycl
elimin
reduc
viru
product
ribosom
frameshift
therefor
provid
uniqu
target
antivir
agent
function
articl
describ
seri
rapid
assay
strategi
develop
use
identifi
potenti
antivir
agent
target
program
ribosom
frameshift
abil
ribosom
maintain
correct
translat
read
frame
fundament
integr
protein
translat
ultim
cell
growth
viabil
thu
protein
translat
machineri
evolv
ensur
intrins
error
rate
readingfram
mainten
extrem
low
per
codon
howev
number
case
elong
ribosom
program
shift
translat
read
frame
one
base
direct
ribosom
frameshift
identifi
tabl
program
ribosom
frameshift
commonli
observ
doublestrand
rna
dsrna
nonseg
strand
rna
virus
program
ribosom
frameshift
shift
ribosom
one
base
direct
also
character
least
two
viral
system
exampl
program
ribosom
frameshift
known
occur
bacteri
gene
one
exampl
program
ribosom
frameshift
document
eukaryot
gene
report
exampl
eukaryot
cellular
mrna
use
program
ribosom
frameshift
differ
ribosom
frameshift
system
extens
review
elsewher
articl
focu
exclus
program
ribosom
frameshift
target
antivir
intervent
specif
discuss
assay
strategi
develop
drug
screen
recent
work
peptidyltransferas
inhibitor
found
antivir
activ
alter
effici
viral
program
ribosom
frameshift
virus
util
program
frameshift
open
read
frame
orf
encod
major
viral
structur
protein
typic
gag
protein
locat
end
mrna
wherea
orf
encod
protein
enzymat
function
typic
pro
pol
locat
end
transcript
frame
gag
orf
fig
enzymat
protein
translat
result
program
ribosom
frameshift
event
occur
effici
depend
specif
viru
assay
system
employ
thu
major
translat
event
result
product
gag
protein
minor
yield
viral
enzymat
protein
fig
effici
frameshift
occur
therefor
determin
ratio
structur
enzymat
protein
avail
virusparticl
assembl
fig
gene
arrang
import
virusparticl
morphogenesi
virus
requir
larg
excess
structur
compon
protein
enzymat
activ
import
maintain
appropri
ratio
factor
demonstr
use
two
endogen
virus
yeast
saccharomyc
cerevisia
result
demonstr
alter
effici
program
ribosom
frameshift
either
direct
chang
ratio
gag
gagpol
protein
synthes
thu
virusparticl
assembl
rna
packag
result
reduc
viral
titr
fig
addit
shown
gross
chang
ratio
gag
gagpol
protein
retrovirus
like
hiv
moloney
murin
leukaemia
viru
interfer
virusparticl
format
studi
suggest
program
ribosom
frameshift
present
novel
target
antivir
therapi
cisact
sequenc
promot
effici
ribosom
frameshift
well
character
sever
viral
system
two
basic
sequenc
element
requir
promot
effici
level
program
ribosom
frameshift
first
sequenc
element
call
slipperi
site
consist
heptam
sequenc
x
xxi
yyz
incom
eg
gag
read
frame
indic
posit
space
xxx
three
ident
nucleotid
yyy
aaa
uuu
z
u
c
fig
second
promot
element
usual
sequenc
form
defin
rna
secondari
structur
rna
pseudoknot
approxim
six
nucleotid
slipperi
site
thought
increas
probabl
ribosom
slip
read
frame
direct
fig
simultan
slippag
ribosomebound
trna
one
base
direct
still
leav
nonwobbl
base
correctli
pair
mrna
new
read
frame
fig
thu
number
ribosom
shift
frame
affect
number
paramet
includ
abil
ribosomebound
trna
unpair
abil
trna
rebind
frame
rel
posit
rna
pseudoknot
slipperi
site
pseudoknot
thermodynam
stabil
fact
program
ribosom
frameshift
appear
viru
specif
make
attract
target
identifi
agent
affect
effici
process
consequ
viru
mainten
envisag
three
major
advantag
program
ribosom
frameshift
therapeut
target
antivir
agent
small
chang
frameshift
effici
larg
effect
viru
product
exampl
increas
decreas
effici
program
ribosom
frameshift
yeast
la
viru
littl
factor
two
interf
abil
tibtech
april
vol
compound
chang
effici
program
ribosom
frameshift
function
concentr
drastic
inhibit
translat
machineri
see
thu
compound
function
therapeut
agent
low
drug
concentr
minim
potenti
toxic
host
describ
greater
detail
demonstr
peptidyltransferas
inhibitor
anisomycin
sparsomycin
effici
inhibit
viral
propag
yeast
killer
viru
concentr
inhibit
cell
growth
protein
synthesi
fact
strategi
target
hostcellular
process
rather
viral
gene
minim
abil
virus
evolv
drugresist
mutant
fig
convent
antivir
strategi
target
virusspecif
protein
exampl
nucleosid
analogu
proteas
inhibitor
commonli
use
class
antivir
agent
target
gene
product
encod
viral
pathogen
fig
howev
therapeut
strategi
gener
select
pressur
mutat
viral
gene
caus
resist
action
drug
drugresist
mutant
therefor
aris
viru
popul
evolv
time
scale
week
month
drug
resist
emerg
rapidli
compound
target
hostcellular
gene
product
involv
regul
program
ribosom
frameshift
sever
advantag
first
select
pressur
hostcellular
translat
machineri
adapt
drug
would
occur
host
evolutionari
time
scale
second
viral
variant
might
overcom
effect
drug
chang
effici
program
ribosom
frameshift
back
wildtyp
level
would
theoret
involv
multipl
mutat
slipperi
site
andor
rna
pseudoknot
accord
rule
govern
process
make
difficult
drugresist
mutant
aris
thu
shift
select
pressur
away
viru
evolutionari
strength
target
program
ribosom
frameshift
minim
abil
virus
evolv
drugresist
mutant
fig
agent
affect
ribosom
frameshift
without
deleteri
inhibit
hostcellular
translat
apparatu
would
excel
candid
antivir
therapi
seri
yeastbas
assay
system
develop
identifi
compound
modul
translat
machineri
alter
program
ribosom
frameshift
effici
advantag
use
yeastbas
assay
system
threefold
ampli
demonstr
basic
molecular
mechan
govern
program
ribosom
frameshift
yeast
human
almost
ident
unlik
mammaliancellcultur
system
wholeanim
model
yeast
cell
grow
rapidli
provid
rapid
result
low
turnaround
time
less
expens
cultur
yeast
maintain
mammalian
cell
whole
anim
reason
yeastbas
assay
system
use
identif
compound
affect
program
ribosom
frameshift
brief
descript
differ
assay
strategi
use
monitor
program
ribosom
frameshift
viru
mainten
three
differ
reporterconstruct
strategi
allow
monitor
program
cell
extract
shown
fig
first
strategi
fig
use
mani
laboratori
typic
use
directli
measur
vivo
vitro
program
ribosom
frameshift
effici
reli
use
two
differ
enzymat
report
construct
assay
parallel
transcriptioniniti
termin
signal
report
gene
two
construct
plasmid
differ
lie
fact
control
plasmid
contain
report
gene
read
frame
translat
start
site
interven
viral
sequenc
result
highlevel
express
report
protein
frameshift
report
construct
contain
virusderiv
program
ribosom
frameshift
signal
insert
start
codon
report
gene
way
report
gene
frame
respect
translat
start
site
thu
report
protein
translat
ribosom
shift
frame
direct
effici
ribosom
frameshift
calcul
determin
ratio
reporterprotein
activ
measur
cell
cell
extract
harbour
frameshift
report
harbour
control
effici
program
ribosom
frameshift
base
ratio
frameshiftreport
activ
effici
program
ribosom
frameshift
alway
normal
effect
drug
overal
translat
monitor
reporterprotein
activ
control
presenc
indic
drug
chang
program
frameshift
determin
calcul
ratio
frameshift
effici
presenc
drug
cell
grown
absenc
drug
second
gener
strategi
fig
program
ribosom
frameshift
result
synthesi
select
marker
protein
use
intact
cell
exampl
increas
express
gene
consequ
increas
program
ribosom
frameshift
effici
use
isol
host
chromosom
frameshift
mutant
although
strategi
measur
program
ribosom
frameshift
effici
directli
could
employ
highthroughput
screen
agent
affect
process
intact
cell
simultaneousslippag
model
program
ribosom
frameshift
program
ribosom
frameshift
signal
locat
region
gag
pol
orf
overlap
b
elong
ribosom
encount
rna
pseudoknot
paus
heptamer
slipperi
site
trna
ribosom
p
site
unpair
codon
slip
back
one
base
nonwobbl
base
rebind
codon
ribosom
unwind
rna
pseudoknot
continu
translat
mrna
new
read
frame
third
gener
strategi
fig
use
bicistron
report
construct
translat
first
report
protein
serv
intern
control
synthesi
second
report
protein
requir
program
ribosom
frameshift
strategi
measur
chang
rel
ratio
two
reporterprotein
activ
particularli
well
suit
cellfre
translat
system
three
assay
stategi
use
provid
rapid
reliabl
method
measur
effect
agent
program
ribosom
frameshift
overal
protein
translat
cell
growth
viabil
one
major
caveat
inher
vivo
strategi
describ
frameshiftreport
gene
contain
termin
codon
thu
encod
unstabl
mrna
substrat
rapid
degrad
via
nonsensemedi
mrnadecay
nmd
pathway
agent
inactiv
nmd
pathway
would
stabil
mrna
result
higher
express
frameshiftreport
protein
appear
increas
effici
program
ribosom
frameshift
thu
second
independ
assay
system
requir
confirm
agent
affect
program
ribosom
frameshift
antivir
activ
killer
program
ribosom
frameshift
assay
strategi
gener
strategi
directli
measur
effici
program
ribosom
frameshift
pictur
control
report
ribosom
frameshift
construct
system
util
report
protein
laczencod
vivo
luciferas
vitro
ribosom
frameshift
construct
report
clone
downstream
program
ribosom
frameshift
signal
frame
translat
start
site
synthesi
report
protein
thu
requir
program
ribosom
frameshift
event
control
report
gene
clone
frame
start
site
lack
interven
viral
frameshift
signal
program
ribosom
frameshift
effici
determin
divid
level
reporterprotein
activ
produc
report
produc
control
multipli
translat
report
occur
intact
yeast
cell
translat
compet
cell
extract
effect
candid
compound
overal
translat
program
ribosom
frameshift
monitor
b
gener
strategi
assay
intact
yeast
cell
detect
chang
program
ribosom
frameshift
effici
use
select
marker
gene
encod
select
marker
clone
downstream
frame
respect
translat
start
site
synthesi
gene
product
requir
program
ribosom
frameshift
event
chang
program
ribosom
frameshift
effici
detect
monitor
abil
cell
grow
posit
select
neg
select
presenc
candid
compound
c
bicistron
construct
measur
chang
program
ribosom
frameshift
effici
reportergen
constitut
control
use
monitor
effect
compound
overal
translat
translat
reportergen
requir
program
ribosom
frameshift
event
chang
program
ribosom
frameshift
effici
detect
monitor
chang
ratio
activ
two
report
protein
cerevisia
serv
model
investig
mechan
govern
ribosom
frameshift
typic
compos
la
helper
viru
satellit
viru
dsrna
genom
la
contain
two
orf
gag
gene
encod
major
viral
coat
protein
gag
pol
gene
encod
multifunct
protein
includ
rnadepend
rna
polymeras
domain
requir
viral
rna
packag
ribosom
frameshift
event
respons
product
la
encod
gagpol
fusion
protein
fig
satellit
dsrna
viru
la
encod
secret
killer
toxin
dsrna
genom
encapsid
replic
insid
icosahedr
la
viral
particl
chang
effici
program
ribosom
frameshift
along
la
mrna
result
rapid
loss
monitor
replicapl
coloni
test
cell
lawn
cell
sensit
killer
toxin
cell
maintain
viru
secret
killer
toxin
creat
ring
growth
inhibit
fig
use
assay
strategi
describ
shown
two
peptidyltransferas
inhibitor
anisomycin
sparsomycin
specif
alter
effici
ribosom
frameshift
yeast
cell
present
subleth
dose
drug
belong
wellcharacter
class
small
molecul
shown
affect
proteinsynthet
machineri
step
ribosom
frameshift
event
thought
occur
exampl
anisomycin
concentr
affect
growth
yeast
cell
rate
protein
translat
effici
program
ribosom
frameshift
alter
cell
harbour
la
virus
grown
concentr
anisomycin
rapid
loss
virus
observ
fig
altern
strategi
involv
use
seri
oligonucleotid
design
bind
specif
sequenc
flank
hiv
frameshift
signal
shown
oligonucleotid
bound
immedi
hiv
frameshift
signal
increas
effici
program
ribosom
frameshift
sixfold
investig
suggest
increas
rna
secondari
structur
downstream
frameshift
site
increas
program
ribosom
frameshift
effici
taken
togeth
result
demonstr
specif
agent
use
modul
translat
machineri
without
inactiv
translat
order
alter
effici
program
frameshift
degre
promot
loss
killer
viru
mani
virus
caus
signific
human
anim
agricultur
diseas
util
program
ribosom
frameshift
regul
product
structur
enzymat
protein
tabl
alter
frameshift
effici
disrupt
viru
life
cycl
elimin
reduc
viru
product
program
ribosom
frameshift
excel
target
compound
function
antivir
agent
predominantli
util
virus
regul
gene
express
small
chang
ribosom
frameshift
effici
achiev
subleth
concentr
chosen
compound
subtl
modul
hostcellular
translat
machineri
result
alter
frameshift
effici
viru
loss
importantli
correct
effici
ribosom
frameshift
determin
part
hostcellular
translat
apparatu
owe
complex
natur
program
ribosom
frameshift
signal
compensatori
viral
mutat
easili
gener
greatli
reduc
likelihood
drugresist
variant
seri
rapid
inexpens
yeastbas
assay
system
develop
identifi
compound
alter
effici
program
ribosom
frameshift
cure
yeast
cell
endogen
viru
clearli
work
requir
determin
whether
compound
use
therapeut
agent
human
viral
diseas
list
virus
util
program
ribosom
frameshift
includ
hiv
caus
agent
aid
demonstr
valu
identifi
agent
function
affect
program
frameshift
reduc
viral
titr
result
assay
present
describ
new
target
fight
viral
diseas
outlin
rapid
costeffect
approach
identifi
potenti
antivir
agent
character
therapeut
valu
interestingli
although
compound
describ
previous
demonstr
antibiot
function
also
altern
strategi
use
potenti
antivir
agent
key
use
agent
modul
hostcellular
translat
machineri
rather
complet
inhibit
function
thu
wellstudi
compound
invalu
bacteri
infect
may
also
util
new
arena
fight
viral
diseas
vitro
rabbit
reticulocyt
extract
anisomycin
specif
decreas
ribosom
frameshift
effici
antivir
activ
effect
anisomycin
program
ribosom
frameshift
assay
intact
yeast
cell
vivo
translat
compet
rabbit
reticulocyt
extract
vitro
indic
drug
concentr
subinhibitori
cell
growth
divis
vivo
overal
translat
vivo
vitro
shown
anisomycin
specif
inhibit
program
ribosom
frameshift
system
b
yeast
cell
harbour
la
virus
cultur
presenc
indic
concentr
anisomycin
indic
time
percentag
cell
retain
killer
activ
determin
